- Home
- TLSA vs DOUG Comparison
TLSA vs DOUG Comparison
Compare TLSA & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- DOUG
- Stock Information
- Founded
- TLSA 2013
- DOUG 1911
- Country
- TLSA United Kingdom
- DOUG United States
- Employees
- TLSA N/A
- DOUG N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- DOUG Building operators
- Sector
- TLSA Health Care
- DOUG Real Estate
- Exchange
- TLSA Nasdaq
- DOUG Nasdaq
- Market Cap
- TLSA 240.0M
- DOUG 225.3M
- IPO Year
- TLSA 2000
- DOUG N/A
- Fundamental
- Price
- TLSA $1.94
- DOUG $2.74
- Analyst Decision
- TLSA
- DOUG
- Analyst Count
- TLSA 0
- DOUG 0
- Target Price
- TLSA N/A
- DOUG N/A
- AVG Volume (30 Days)
- TLSA 336.7K
- DOUG 388.6K
- Earning Date
- TLSA 05-06-2025
- DOUG 11-03-2025
- Dividend Yield
- TLSA N/A
- DOUG N/A
- EPS Growth
- TLSA N/A
- DOUG N/A
- EPS
- TLSA N/A
- DOUG N/A
- Revenue
- TLSA N/A
- DOUG $1,034,406,000.00
- Revenue This Year
- TLSA N/A
- DOUG $17.61
- Revenue Next Year
- TLSA N/A
- DOUG N/A
- P/E Ratio
- TLSA N/A
- DOUG N/A
- Revenue Growth
- TLSA N/A
- DOUG 8.69
- 52 Week Low
- TLSA $0.63
- DOUG $1.48
- 52 Week High
- TLSA $2.60
- DOUG $3.20
- Technical
- Relative Strength Index (RSI)
- TLSA 47.55
- DOUG 51.33
- Support Level
- TLSA $1.81
- DOUG $2.46
- Resistance Level
- TLSA $2.04
- DOUG $2.58
- Average True Range (ATR)
- TLSA 0.18
- DOUG 0.13
- MACD
- TLSA -0.03
- DOUG -0.01
- Stochastic Oscillator
- TLSA 25.00
- DOUG 55.65
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.